... Prior to joining IPG, Reynolds held numerous sales leadership positions during his 24 years at Guidant Corporation and Boston Scientific. Early in his career, Reynolds helped lead Eli Lilly and Company's Medical Device and Diagnostic Division's...
...GROUP Company Profile - Kimberly-Clark Corporation Company Profile - GlaxoSmithKline plc Company Profile - Boston Scientific Corporation Company Profile - Synthes GmbH Company Profile - Zimmer Holdings, Inc. Company Profile - Smiths Medical...
...next-generation stents with biodegradable drug-eluting polymers will likely eventually overtake the current technology from Boston Scientific, Abbott Labs (NYSE: ABT), Medtronic (NYSE: MDT), and Johnson & Johnson (NYSE: JNJ), because the removal of the...
...year. European launch of a new drug-eluting stent incorporating this technology is planned following regulatory approval. Boston Scientific plans to evaluate the Labcoat technology for use on both its paclitaxel and everolimus families of drug-eluting stents....
...is also vacating as much as 90,000 square feet of leased office space at Cochituate Place in Natick, the brokers said. Boston Scientific spokesman Paul Donovan declined to comment, but the company appears to be shedding space for two reasons. First, it...
...2015. The report profiles 53 companies including many key and niche players worldwide such as Angiotech Pharmaceuticals, Boston Scientific Corp., Cordis Corporation (JNJ), Cook Group, Inc., Medtronic, Inc., Medtronic Vascular, Inc., MIVI Technologies...
Background
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
You must have Javascript and Flash version 8+ enabled to see this content.
Timeline
You must have Javascript and Flash version 8+ enabled to see this content.
Jay Ethridge said this in:
8 hours ago from PR-Inside.com